Prognostic Significance of Molecular Follow-up by Qualitative and Real-Time Quantitative Reverse-Transcriptase Polymerase Chain Reaction in TEL/AML1–Positive Childhood Acute Lymphoblastic Leukemia
Authors:
- Gisella VolpeGVGisella Volpe
- Nicoletta BertorelloNBNicoletta Bertorello
- Elena BarisoneEBElena Barisone
- Stefano UliscianiSUStefano Ulisciani
- Enrico GottardiEGEnrico Gottardi
- Daniela CilloniDCDaniela Cilloni
- Marco VignettiMVMarco Vignetti
- Carlo LanzaCLCarlo Lanza
- Franca FagioliFranca Fagioli
- Enrico MadonEMEnrico Madon
- Giuseppe SaglioGSGiuseppe Saglio
- 30 September 2007
- journal article
- Published by Elsevier in Clinical Leukemia
- Vol. 1 (5) , 298-303
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Prospective analysis of TEL/AML1-positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95-01Blood, 2006
- Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer ProgramLeukemia, 2003
- Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol IIBlood, 2002
- TEL/AML1-positive pediatric leukemia: prognostic significance and therapeutic approachesCurrent Opinion in Hematology, 2002
- Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocolBritish Journal of Haematology, 2001
- Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual diseaseLeukemia, 1999
- TEL-AML1 Fusion Transcript in Relapsed Childhood Acute Lymphoblastic LeukemiaBlood, 1998
- Incidence of TEL/AML1 Fusion Gene Analyzed Consecutively in Children With Acute Lymphoblastic Leukemia in RelapseBlood, 1997
- TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemiaBlood, 1996
- TEL-AML1 fusion RNA as a new target to detect minimal residual disease in pediatric B-cell precursor acute lymphoblastic leukemiaBlood, 1996